Boehringer Ingelheim receives FDA approval for SENVELGO® (velagliflozin oral solution): the first oral liquid medication for diabetes in cats
/PRNewswire/ -- Boehringer Ingelheim announced today that SENVELGO® (velagliflozin oral solution), a revolutionary new treatment for cats with diabetes, has...
United States University Of Georgia Prnewswire Boehringer Ingelheim Boehringer Ingelheim Vetmedica Gmb Us Boehringer Ingelheim Susan Gottlieb Jacquie
Source: prnewswire.com